A Study Assessing the Long-Term Safety and Tolerability of Galegenimab (FHTR2163) in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration

PHASE2TerminatedINTERVENTIONAL
Enrollment

144

Participants

Timeline

Start Date

November 16, 2020

Primary Completion Date

November 14, 2022

Study Completion Date

November 14, 2022

Conditions
Macular Degeneration, Age-RelatedGeographic Atrophy
Interventions
DRUG

Galegenimab

Intravitreal (ITV) injections of galegenimab

Trial Locations (48)

11572

Ophthalmic Consultants of Long Island, Oceanside

19107

Mid Atlantic Retina - Wills Eye Hospital, Philadelphia

21287

Johns Hopkins University, Baltimore

28210

Charlotte Eye Ear Nose and Throat Associates PA, Charlotte

28803

Western Carolina Retinal Associate PA, Asheville

29169

Palmetto Retina Center, West Columbia

30909

Southeast Retina Center, Augusta

32308

Southern Vitreoretinal Associates, Tallahassee

32503

Retina Specialty Institute, Pensacola

32901

Florida Eye Associates - Melbourne 2nd Office, Melbourne

33064

Rand Eye, Deerfield Beach

33711

Retina Vitreous Assoc of FL, St. Petersburg

37203

Tennessee Retina PC, Nashville

37421

Southeastern Retina Associates Chattanooga, Chattanooga

38138

Charles Retina Institute, Germantown

45242

Cincinnati Eye Institute, Cincinnati

48073

Associated Retinal Consultants PC, Royal Oak

49546

Vitreo-Retinal Associates, Grand Rapids

50266

Wolfe Eye Clinic, West Des Moines

53705

University of Wisconsin, Madison

60612

Illinois Eye and Ear Infirmary, Chicago

63017

Midwest Vision Research Foundation, Chesterfield

63128

The Retina Institute, St Louis

67214

Vitreo Retinal Consultants, Wichita

75231

Retina Foundation of the Southwest, Dallas

78750

Austin Clinical Research LLC, Austin

80228

Colorado Retina Associates, PC, Lakewood

80909

Retina Consultants of Southern Colorado PC, Colorado Springs

81303

Southwest Retina Consultants, Durango

89502

Sierra Eye Associates, Reno

91436

The Retina Partners, Encino

92064

Retina Consultants, San Diego, Poway

93103

California Retina Consultants, Santa Barbara

93309

California Retina Consultants, Bakersfield

93454

California Retina Consultants - Santa Maria, Santa Maria

94040

Northern California Retina Vitreous Associates, Mountain View

94598

Bay Area Retina Associates, Walnut Creek

95825

Retinal Consultants Med Group, Sacramento

97239

Casey Eye Institute, Portland

99204

Spokane Eye Clinical Research, Spokane

92835-3424

Retina Consultants of Orange County, Fullerton

94109-5520

West Coast Retina, San Francisco

30060-1137

Georgia Retina PC, Marietta

08755

NJ Retina Teaneck Clinic, Toms River

NJ Retina-Toms River, Toms River

44195-0001

Cleveland Clinic Foundation; Cole Eye Institute, Cleveland

78705-1169

Austin Retina Associates, Austin

77384-4167

Retina Consultants of Texas, The Woodlands

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Genentech, Inc.

INDUSTRY

NCT04607148 - A Study Assessing the Long-Term Safety and Tolerability of Galegenimab (FHTR2163) in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration | Biotech Hunter | Biotech Hunter